1.Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets
Dae-Hee KIM ; In-Jeong CHO ; Woohyeun KIM ; Chan Joo LEE ; Hyeon-Chang KIM ; Jeong-Hun SHIN ; Si-Hyuck KANG ; Mi-Hyang JUNG ; Chang Hee KWON ; Ju-Hee LEE ; Hack Lyoung KIM ; Hyue Mee KIM ; Iksung CHO ; Dae Ryong KANG ; Hae-Young LEE ; Wook-Jin CHUNG ; Kwang Il KIM ; Eun Joo CHO ; Il-Suk SOHN ; Sungha PARK ; Jinho SHIN ; Sung Kee RYU ; Seok-Min KANG ; Wook Bum PYUN ; Myeong-Chan CHO ; Ju Han KIM ; Jun Hyeok LEE ; Sang-Hyun IHM ; Ki-Chul SUNG
Korean Circulation Journal 2022;52(6):460-474
Background and Objectives:
This study aimed to investigate the association between cardiovascular events and 2 different levels of elevated on-treatment diastolic blood pressures (DBP) in the presence of achieved systolic blood pressure targets (SBP).
Methods:
A nation-wide population-based cohort study comprised 237,592 patients with hypertension treated. The primary endpoint was a composite of cardiovascular death, myocardial infarction, and stroke. Elevated DBP was defined according to the Seventh Report of Joint National Committee (JNC7; SBP <140 mmHg, DBP ≥90 mmHg) or to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) definitions (SBP <130 mmHg, DBP ≥80 mmHg).
Results:
During a median follow-up of 9 years, elevated on-treatment DBP by the JNC7 definition was associated with an increased risk of the occurrence of primary endpoint compared with achieved both SBP and DBP (adjusted hazard ratio [aHR], 1.14; 95% confidence interval [CI], 1.05–1.24) but not in those by the 2017 ACC/AHA definition. Elevated ontreatment DBP by the JNC7 definition was associated with a higher risk of cardiovascular mortality (aHR, 1.42; 95% CI, 1.18–1.70) and stroke (aHR, 1.19; 95% CI, 1.08–1.30). Elevated on-treatment DBP by the 2017 ACC/AHA definition was only associated with stroke (aHR, 1.10;95% CI, 1.04–1.16). Similar results were seen in the propensity-score-matched cohort.
Conclusion
Elevated on-treatment DBP by the JNC7 definition was associated a high risk of major cardiovascular events, while elevated DBP by the 2017 ACC/AHA definition was only associated with a higher risk of stroke. The result of study can provide evidence of DBP targets in subjects who achieved SBP targets.
2.Effect of Peritoneal Dialysis Modality on the 1-Year Rate of Decline of Residual Renal Function.
Chan Ho KIM ; Hyung Jung OH ; Mi Jung LEE ; Young Eun KWON ; Yung Ly KIM ; Ki Heon NAM ; Kyoung Sook PARK ; Seong Yeong AN ; Kwang Il KO ; Hyang Mo KOO ; Fa Mee DOH ; Seung Hyeok HAN ; Tae Hyun YOO ; Beom Seok KIM ; Shin Wook KANG ; Kyu Hun CHOI
Yonsei Medical Journal 2014;55(1):141-148
PURPOSE: The effect of different peritoneal dialysis (PD) modalities on the decline in residual renal function (RRF) is unclear due to inconsistencies among studies. In particular, the effect of automated peritoneal dialysis (APD) modalities [continuous cyclic peritoneal dialysis (CCPD) and nightly intermittent peritoneal dialysis (NIPD)] on RRF has not been examined in a large cohort. MATERIALS AND METHODS: We conducted a single-center retrospective study to investigate the association between PD modalities and decline in RRF in 142 incident PD patients [34 on CCPD, 36 on NIPD, and 72 on continuous ambulatory peritoneal dialysis (CAPD)]. RRF was measured within 2 months from PD start and at 1 year after PD initiation. RESULTS: The RRF at 1 year after PD initiation was 1.98+/-2.20 mL/min/1.73 m2 in CCPD patients and 3.63+/-3.67 mL/min/1.73 m2 in NIPD patients, which were moderately lower than 4.23+/-3.51 mL/min/1.73 m2 in CAPD patients (p=0.064). Moreover, there was no significant difference in the 1-year rate of decline of RRF between CCPD and NIPD patients, although APD patients had a faster 1-year RRF decline rate than CAPD patients (CCPD and NIPD vs. CAPD: -45.68 and -36.69 vs. 1.17%/year, p=0.045). APD was associated with a more rapid decline in RRF in patients with end-stage renal disease undergoing PD, although multivariate analysis attenuated the significance of this finding (beta=-31.50; 95% CI, -63.61 to 0.62; p=0.052). CONCLUSION: Our results suggest that CAPD might be more helpful than APD for preserving RRF during the first year of dialysis therapy, although there was no significant difference in the 1-year rate of decline of RRF between the two APD modalities.
Adult
;
Female
;
Glomerular Filtration Rate/physiology
;
Humans
;
Kidney/pathology/physiopathology
;
Kidney Failure, Chronic/*therapy
;
Male
;
Middle Aged
;
Peritoneal Dialysis/*adverse effects
;
Retrospective Studies
3.Stepwise Treatment Using Corticosteroids Alone and in Combination with Cyclosporine in Korean Patients with Idiopathic Membranous Nephropathy.
Dong Ho SHIN ; Mi Jung LEE ; Hyung Jung OH ; Hyang Mo KOO ; Fa Mee DOH ; Hyoung Rae KIM ; Jae Hyun HAN ; Jung Tak PARK ; Seung Hyeok HAN ; Kyu Hun CHOI ; Tae Hyun YOO ; Shin Wook KANG
Yonsei Medical Journal 2013;54(4):973-982
PURPOSE: We undertook an observational study to investigate the effects of immunosuppressive treatment on proteinuria and renal function in 179 Korean idiopathic membranous nephropathy patients with nephrotic syndrome. MATERIALS AND METHODS: The primary outcome was regarded as the first appearance of remission and the secondary outcomes as a decline in estimated glomerular filtration rate (eGFR) >50% or initiation of dialysis, and all-cause mortality. Seventy-two (40.2%) and 50 (27.9%) patients were treated with corticosteroids alone (C) and corticosteroids plus cyclosporine (C+C), respectively, whereas 57 (31.8%) did not receive immunosuppressants (NTx). Cyclosporine was added if there was no reduction in proteinuria of >50% from baseline by corticosteroids alone within 3 months. RESULTS: There were no differences in baseline renal function and the amount of proteinuria among the three groups. Overall, complete remission (CR) was achieved in 88 (72.1%) patients by immunosuppressants. In a multivariate analysis adjusted for covariates associated with adverse renal outcome, the probability of reaching CR was significantly higher in the C [hazard ratio (HR), 4.09; p<0.001] and C+C groups (HR, 2.57; p=0.003) than in the NTx group. Kaplan-Meier analysis revealed that 5-year CR rates of C, C+C, and NTx groups were 88.5%, 86.2%, and 56.7% (p<0.001). Ten-year event-free rates for the secondary endpoints in these three groups were 91.7%, 79.9%, and 57.2% (p=0.01). CONCLUSION: Immunosuppressive treatment was effective in inducing remission and preserving renal function in these patients. Therefore, stepwise treatment using corticosteroids alone and in combination with cyclosporine is warranted in these patients.
Adrenal Cortex Hormones/adverse effects/*therapeutic use
;
Adult
;
Aged
;
Cyclosporine/adverse effects/*therapeutic use
;
Drug Administration Schedule
;
Female
;
Glomerular Filtration Rate/drug effects
;
Glomerulonephritis, Membranous/*drug therapy/mortality
;
Humans
;
Immunosuppressive Agents/adverse effects/*therapeutic use
;
Kaplan-Meier Estimate
;
Kidney/drug effects/physiology
;
Male
;
Middle Aged
;
Proteinuria/chemically induced
;
Treatment Outcome
4.Membranous glomerulonephritis in a patient with myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia.
Kwang Il KO ; Mi Jung LEE ; Fa Mee DOH ; Hyang Mo KOO ; Chan Ho KIM ; Dong Ho SHIN ; Hyung Jung OH ; Seung Hyeok HAN ; Shin Wook KANG ; Kyu Hun CHOI ; Tae Hyun YOO
Kidney Research and Clinical Practice 2013;32(3):134-137
A 74-year-old woman presented with edema in the lower extremities. Laboratory tests revealed anemia, thrombocytopenia, hypoalbuminemia, hypercholesterolemia, and nephrotic-range proteinuria. Myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia (MDS-RCMD) was confirmed by bone marrow biopsy. Renal biopsy demonstrated membranous glomerulonephritis (MGN), stage I. Based on these clinicopathologic results, she was diagnosed as having MGN with MDS-RCMD. This is a rare case report of MGN in a parient with MDS-RCMD featuring nephrotic syndrome.
Aged
;
Anemia
;
Biopsy
;
Bone Marrow
;
Edema
;
Female
;
Glomerulonephritis, Membranous*
;
Humans
;
Hypercholesterolemia
;
Hypoalbuminemia
;
Lower Extremity
;
Myelodysplastic Syndromes
;
Nephrotic Syndrome
;
Proteinuria
;
Thrombocytopenia
5.Minimal Change Nephrotic Syndrome Developed after Thymectomy in a Patient with Thymoma.
Fa Mee DOH ; Seon Jung JANG ; Hyang Mo KOO ; Eun Jin KIM ; Hye Sun SHIN ; Seung Hyeok HAN ; Shin Wook KANG ; Kyu Hun CHOI ; Tae Hyun YOO
Korean Journal of Nephrology 2011;30(4):404-408
We report a case of patient with malignant thymoma, who developed nephrotic syndrome several years after thymectomy. This 38-year-old man was diagnosed as myasthenia gravis and malignant thymoma and underwent thymectomy in 2004. Tumor resection and systemic chemotherapy were performed after recurrence in pleura in 2006. He also took pyridostigmine to control his symptoms of myasthenia gravis after thymectomy. Four years later, even though there was no evidence of recurrence of thymoma, he developed a nephrotic syndrome and was diagnosed as a minimal change disease on renal biopsy. After pulse therapy with methylprednisolone followed by oral administration of prednisolone therapy, nephrotic syndrome was improved.
Administration, Oral
;
Adult
;
Biopsy
;
Humans
;
Methylprednisolone
;
Myasthenia Gravis
;
Nephrosis, Lipoid
;
Nephrotic Syndrome
;
Pleura
;
Prednisolone
;
Pyridostigmine Bromide
;
Recurrence
;
Thymectomy
;
Thymoma
6.Characterization of Monoclonal Antibodies against Human Leukocyte Common Antigen (CD45).
Hyang Mi SHIN ; Woon Dong CHO ; Geon Kook LEE ; Seon Hwa LEE ; Kyung Mee LEE ; Gil Yong JI ; Sang Soon YOON ; Ji Hae KOO ; Ho Chang LEE ; Ki Hyeong LEE ; Hyung Geun SONG
Immune Network 2011;11(2):114-122
BACKGROUND: The leukocyte common antigen (CD45) is a transmembrane-type protein tyrosine phosphatase that has five isoforms. METHODS: We generated seven murine mAbs against human CD45 by injecting cells from different origins, such as human thymocytes, PBMCs, and leukemic cell lines. By using various immunological methods including flow cytometry, immunohistochemistry, and immunoprecipitation, we evaluated the reactivity of those mAbs to CD45 of thymus as well as tonsil lysates. Furthermore, we transiently transfected COS-7 cells with each of gene constructs that express five human CD45 isoforms respectively, and examined the specificities of the mAbs against the transfected isoforms. RESULTS: In case of thymocytes, lymphocytes, and monocytes, all the seven mAbs demonstrated positive reactivities whereas none was reactive to erythrocytes and platelets. The majority of immune cells in formalin-fixed paraffin-embedded thymus and tonsil tissues displayed strong membranous immunoreactivity, and the main antigen was detected near 220 kDa in all cases. Among the mAbs, four mAbs (AP4, DN11, SHL-1, and P6) recognized a region commonly present in all the five isoforms. One mAb, YG27, recognized four isoforms (ABC, AB, BC, and O). Two mAbs, P1 and P14, recognized the isoforms that contain exon A encoded regions (ABC and AB). CONCLUSION: In this study, we confirmed that AP4, DN11, SHL-1, YG27 and P6, are mAbs reactive with the CD45 antigen whereas P1 and P14 are reactive with the CD45RA antigen.
Animals
;
Antibodies, Monoclonal
;
Antigens, CD45
;
Blood Platelets
;
Cell Line
;
COS Cells
;
Erythrocytes
;
Exons
;
Flow Cytometry
;
Humans
;
Immunohistochemistry
;
Immunoprecipitation
;
Leukocytes
;
Lymphocytes
;
Monocytes
;
Palatine Tonsil
;
Protein Isoforms
;
Protein Tyrosine Phosphatases
;
Thymocytes
;
Thymus Gland
7.Healthcare-Associated Infection Surveillance in Small and Medium Sized Hospitals.
Eun Suk PARK ; Hye Young JIN ; Sun Young JEONG ; Oh Mee KWEON ; So Yeon YOO ; Shin Yong PARK ; Sung Ran KIM ; Hae Kyung HONG ; Og Sun KIM ; Kyung Mi KIM ; Sung Won YOON ; Jae Sim JEONG ; Dongeun YONG ; Muyng Soo KIM ; Dae Won PARK ; Yong Kyun CHO ; Hyang Soon OH ; Joon Sup YEOM ; Eui Chong KIM
Korean Journal of Nosocomial Infection Control 2011;16(2):54-62
BACKGROUND: The purpose of this study is to know the healthcare-associated infection (HAI)s in small and medium sized hospitals, less than 400 beds. METHODS: We had web based surveillance for HAIs in 27 hospitals from August to October 2010. The surveillance performed in 1-2 ICUs and 1 general ward in each hospitals by CDC definition. And for the multi-drug resistant organisms (MDROs), we reviewed all of blood culture results. RESULTS: We identified 319 HAIs among 269,436 patients days. The HAIs rate was 1.18 (CI 1.05-1.32)/1,000 patient-days. Urinary tract infection was the most common HAI (52.4%) in this study followed by pneumonia (18.9%), blood-stream infections (14.2%), surgical site infection (7.9%), and others (6.6%). There were 76.5% of device associated infections in UTI, 46.7% in BSI, and 18.3% in pneumonia. The rate of HAIs in ICU was higher than that of in general ward (4.6 vs 0.9/1,000 patient-days). However, the indwelling catheter associated urinary tract infection rate was lower in ICU (2.6 vs 4.4/1,000 device days). There were no significant differences in central line-associated blood stream infection rate (1.5 vs 1.8) and ventilator-associated pneumonia rate (3.0 vs 0.0). The common microorganisms found in HAIs were Escherichia coli (19.8%), Staphylococcus aureus (13.1%), and Pseudomonas aeruginosa (12.7%). Moreover, 90.9% of S. aureus were resistant to methicillin, and 38.2% of P. aeruginosa and 44.4% of Acinetobacter baumannii were resistant to imipenem. Total of 66 MDROs were isolated from blood culture and the result shows that the MRSA was 84.6% (56 case), carbapenmen-resistant Acinetobacter spp. was 10.6% (7 case), and vancomycin-resistant enterococci was 4.6% (3 case). CONCLUSION: The characteristics of HAIs in small and medium sized hospitals will be contributed to the decision making of governance policy for infection control and to provide comparable data for these hospitals.
Acinetobacter
;
Acinetobacter baumannii
;
Catheters, Indwelling
;
Centers for Disease Control and Prevention (U.S.)
;
Decision Making
;
Escherichia coli
;
Humans
;
Imipenem
;
Infection Control
;
Methicillin
;
Methicillin-Resistant Staphylococcus aureus
;
Patients' Rooms
;
Pneumonia
;
Pneumonia, Ventilator-Associated
;
Pseudomonas aeruginosa
;
Rivers
;
Staphylococcus aureus
;
Urinary Tract Infections
8.A Case of Peritonitis caused by Chryseobacterium meningosepticum in a Patient Treated with Peritoneal Dialysis.
Hyang Mo KOO ; Fa mee DOH ; Eun Jin KIM ; Ea Wha KANG ; Suk Kyun SHIN ; Tae Ik CHANG
Korean Journal of Nephrology 2011;30(3):339-342
Chryseobacterium meningosepticum is rarely encountered as a pathogen causing peritonitis in peritoneal dialysis (PD) patients. We report a case of peritonitis due to Chryseobacterium meningosepticum, which was treated successfully with intraperitoneal (IP) vancomycin and ciprofloxacin, and without PD catheter removal. Peritonitis was developed in a 53-year-old PD patient on the third hospital day. Although empirical IP treatment with cefazolin and tobramycin was initiated and maintained for 3 days, the fever and signs of peritonitis persisted. Antibiotics were changed to cefoperazone/sulbactam, amikacin, and vancomycin due to clinical deterioration. After 3 days of vancomycin use, leukocyte count in PD fluid was less than 100/mm3 and the patient became asymptomatic. On seventh day after the onset of peritonitis, Chryseobacterium meningosepticum was isolated from initial dialysate sample, and this strain was susceptible to ciprofloxacin, piperacillin, and piperacillin/tazobactam. Accordingly, we changed the antibiotics to ciprofloxacin and vancomycin, which were given for the total of 14 days. Even though Chryseobacterium meningosepticum is an uncommon causative organism of peritonitis in PD patients, this report suggests that vancomycin and ciprofloxacin are effective as empiric therapy, and early suspicion and appropriate antimicrobial therapy are crucial to the successful treatment of peritonitis due to Chryseobacterium meningosepticum without catheter removal.
Amikacin
;
Anti-Bacterial Agents
;
Catheters
;
Cefazolin
;
Chryseobacterium
;
Ciprofloxacin
;
Fever
;
Humans
;
Leukocyte Count
;
Middle Aged
;
Peritoneal Dialysis
;
Peritonitis
;
Piperacillin
;
Sprains and Strains
;
Tobramycin
;
Vancomycin
9.A Case of Erythrocytosis Improved after Kidney Transplantation.
Hyang Mo KOO ; Eun Jin KIM ; Fa mee DOH ; Shin Wook KANG ; Kyu Hun CHOI ; Tae Hyun YOO
Korean Journal of Nephrology 2011;30(2):220-224
Renal anemia is a common complication of chronic kidney disease and known to be caused by erythropoietin or iron deficiency. However, erythrocytosis in patients on dialysis has rarely been reported and usually associated with renal cell carcinoma, polycythemia vera or acquired cystic kidney disease. Here we report a case of erythrocytosis in an ESRD patient with resolution after kidney transplantation. A 38-year-old man on peritoneal dialysis for 5 years was admitted for kidney transplantation. On admission, blood Hgb and Hct was 19.7 g/dL and 61.4%, respectively. Serum erythropoietin level was 347 mIU/mL. Multiple variable sized cystic lesions were identified on both kidneys without evidence of internal malignancy in abdomen and pelvis CT scan. After kidney transplantation, Hgb was 12.5 g/dL and serum erythropoietin level was 13.1 mIU/mL. Some of renal cysts on CT scan disappeared or decreased in size. This finding suggests that erythrocytosis in this patient can be associated with acquired cystic kidney disease.
Abdomen
;
Adult
;
Anemia
;
Carcinoma, Renal Cell
;
Dialysis
;
Erythropoietin
;
Humans
;
Iron
;
Kidney
;
Kidney Diseases, Cystic
;
Kidney Failure, Chronic
;
Kidney Transplantation
;
Pelvis
;
Peritoneal Dialysis
;
Polycythemia
;
Polycythemia Vera
;
Renal Insufficiency, Chronic
10.Experience with a Simulation Drill for Novel Influenza A (H1N1).
Dongsuk LEE ; Eun Suk PARK ; Mee Kweon OH ; Hyang Suk KIM ; Jeong Yeon PARK ; Shin Ok KOH ; Min Hong JWA ; In Cheol PARK ; Kyeong Ae KIM ; Kyeong Hwan OH ; Chang Oh KIM ; Sang Hun HAN ; Jun Yong CHOI ; June Myung KIM ; Ju Hyun LEE ; Eun Jin HA ; Dong Soo KIM ; Dongsik BANG ; Kyungwon LEE
Korean Journal of Nosocomial Infection Control 2010;15(2):103-111
BACKGROUND: It is important that hospitals conduct disaster drills to ensure prompt response in case of a pandemic and thereby prevent a biological disaster. METHODS: In a university hospital of Seoul, a drill was arranged by the members of the drill preparation team who were a part of the response team for infection control of novel influenza A (H1N1). The drill preparation team designed the scenario for the drill, made plans to resolve the potential problems that could occur during that scenario, and organized a survey team and a survey methodology. The scenario consisted of 2 modules: (1) for an intensive care unit and (2) for an emergency care center. The surveyors and field participants were evaluated after the drill exercise. RESULTS: This drill was conducted to improve the response to outbreaks of new infectious diseases. The drill event showed that the communication among the members responsible for the infection control was effective. However, the drill revealed certain drawbacks in the process; this drawbacks involved availability of adequate quarantine space, education on using personal protective equipments, assignment of medical and nonmedical staff, management of visitors, and installment of air-conditioners, heaters, and ventilation units in the areas with H1N1 outbreak. CONCLUSION: This drill helped to improve the process of infection control and overcome the drawbacks in the current process, and thereby helped in achieving positive outcome during the actual pandemic situation when the number of hospital visits and admissions because of H1N1 pandemic had rapidly increased. Although disaster plans and drills are not actively performed, the drill for infection control is essential because the risk for an outbreak of a new infectious disease is increasing.
Communicable Diseases
;
Surveys and Questionnaires
;
Dietary Sucrose
;
Disasters
;
Disease Outbreaks
;
Emergency Medical Services
;
Humans
;
Infection Control
;
Influenza, Human
;
Intensive Care Units
;
Mandrillus
;
Pandemics
;
Quarantine
;
Ventilation

Result Analysis
Print
Save
E-mail